
Telmivol AMH 40mg/5mg/12.5mg Tablet
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmivol AMH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Telmisartan 40mg/5mg/12.5mg tablets are a triple-drug formulation for managing hypertension when monotherapy proves insufficient. This combination effectively reduces elevated blood pressure, mitigating the risk of future strokes and heart attacks. This medication may be taken with or without food, following your doctor's prescribed dosage based on your individual response. Consistent daily dosing at the same time is recommended. Continue treatment as directed by your physician; discontinuation may increase stroke or heart attack risk. The formulation includes a diuretic, potentially increasing urination; therefore, avoid dosing within four hours of bedtime. Regular use, even during symptom-free periods, is crucial for optimal benefit, as hypertension is often asymptomatic. Common side effects may encompass headache, dizziness, lethargy, altered taste perception, fatigue, influenza-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to alleviate potential side effects such as thirst, dry mouth, or muscle weakness. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions. Pregnant or lactating individuals should seek medical counsel before use. Complete disclosure of all medications, especially those for hypertension or heart conditions, is essential. Regular monitoring of blood pressure, kidney function, electrolyte balance, and blood glucose is necessary to ensure treatment efficacy.
Primary Ingredients of Telmivol AMH 40mg/5mg/12.5mg Tablet
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Telmivol AMH 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Telmivol AMH 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmivol AMH 40mg/5mg/12.5mg Tablets can be administered with or without food, although consistent daily timing is recommended.
Common Side effects of Telmivol AMH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmivol AMH 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Telmivol AMH 40mg/5mg/12.5mg Tablet should be swallowed whole; do not break, crush, or chew it. While you can take it with or without food, consistent timing is recommended.
How Telmivol AMH 40mg/5mg/12.5mg Tablet works:
Each Telmivol AMH 40mg/5mg/12.5mg tablet contains telmisartan, amlodipine, and hydrochlorothiazide. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, act synergistically to dilate blood vessels, reducing blood pressure. Hydrochlorothiazide, a thiazide diuretic, promotes diuresis, eliminating excess fluid and electrolytes, and contributes to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Telmivol AMH 40mg/5mg/12.5mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Telmivol AMH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Prescription may be considered only in exceptional, life-threatening circumstances where potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
Use of Telmivol AMH 40mg/5mg/12.5mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Driving ability may be impaired by Telmivol AMH 40mg/5mg/12.5mg Tablet side effects. These side effects can include dizziness, headache, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmivol AMH 40mg/5mg/12.5mg tablets, as dosage modification may be necessary. A physician's consultation is advised. Telmivol AMH 40mg/5mg/12.5mg tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Telmivol AMH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Telmivol AMH 40mg/5mg/12.5mg Tablet :
Should you forget a Telmivol AMH 40mg/5mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmivol AMH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
